Skip to main
NGVT
NGVT logo

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp's management demonstrates a strong commitment to enhancing the company's portfolio, particularly through recent asset sales aimed at reducing operational noise. This strategic execution is expected to lower earnings volatility and improve the overall margin profile of the business, signifying a positive trajectory for financial performance. The company's reliance on its Performance Chemicals segment, which generates the bulk of its revenue, coupled with targeted operational improvements, aligns well with the outlook for sustained growth.

Bears say

Ingevity Corp faces significant challenges tied to the potential decline in global auto production, which could severely impact earnings if the company fails to transition its customer base towards AFA technologies. The anticipated margins of 4-5% suggest that any proceeds from sales would imply transaction multiples considerably exceeding prior expectations, raising concerns about sustainability. Additionally, multiple risks, including the effects of a patent cliff, automotive tariffs, and competitive pressures in the Performance Materials segment, further contribute to a negative outlook on the company's financial performance.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.